Transcatheter Embolization and Occlusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Non-Coil is the fastest growing segment, North America is the largest regional market

The Global Transcatheter Embolization And Occlusion Devices Market, valued at USD 3.52 Billion in 2024, is projected to experience a CAGR of 6.92% to reach USD 5.26 Billion by 2030. Transcatheter embolization and occlusion devices are specialized instruments for minimally invasive procedures that block or reduce blood flow to targeted anatomical regions, treating conditions like tumors and aneurysms. Market growth is driven by the increasing global prevalence of chronic diseases, particularly cancer and vascular disorders requiring advanced therapies. A rising preference for minimally invasive interventions, offering reduced patient trauma and quicker recovery, further propels demand. Continuous technological advancements enhancing device efficacy and safety also support broader adoption.

Key Market Drivers

The burgeoning global prevalence of target diseases significantly underpins the expansion of the transcatheter embolization and occlusion devices market. Conditions such as cardiovascular disease, cancer, and aneurysms necessitate advanced therapeutic interventions, directly increasing the demand for effective treatment modalities. For instance, according to the Journal of the American College of Cardiology (JACC), in 2023, there were 626 million prevalent cases of cardiovascular disease globally, a substantial patient population often requiring embolization or occlusion procedures.

Key Market Challenges

A substantial challenge impeding the expansion of the global transcatheter embolization and occlusion devices market is the scarcity of adequately trained interventional specialists. The intricate nature of transcatheter procedures necessitates a high level of expertise and specialized training, which directly restricts the volume of procedures performed and consequently limits market penetration. This limitation is particularly pronounced in developing healthcare systems where training infrastructure may be less established. The absence of sufficient training programs directly impacts the availability of qualified practitioners capable of utilizing these advanced devices.

Key Market Trends

Artificial intelligence integration is profoundly reshaping transcatheter embolization and occlusion procedures through enhanced planning, guidance, and analysis. This technology improves diagnostic precision and optimizes treatment, fostering more effective patient outcomes. A EuroAIM/EuSoMII 2024 survey of European Society of Radiology members indicated 47.9% of respondents actively employed AI systems in their clinical practice. This demonstrates a clear adoption trajectory. Clinical utility is further exemplified by a June 2025 study in the Journal of Neurointerventional Surgery, where an AI-based system, Neuro-Vascular Assist by iMed technologies, facilitated liquid embolization procedures. The system achieved 100% precision and 92.0% recall in real-time agent spread notification, prompting operator intervention in 28.3% of instances, thereby enhancing procedural safety and control.

Key Market Players Profiled:

• Boston Scientific Corp
• Terumo Corp
• Medtronic PLC
• DePuy Synthes Inc
• Stryker Corp
• Cordis Corp
• Abbott Laboratories Inc
• Pfizer Inc
• Sirtex Medical Inc
• Nordion Inc

Report Scope:

In this report, the Global Transcatheter Embolization And Occlusion Devices Market has been segmented into the following categories:

By Product:

• Coil
• Non-Coil

By Application:

• Peripheral Vascular Disease
• Oncology
• Neurology
• Urology
• Others

By Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Transcatheter Embolization And Occlusion Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.